Genetic Testing MarketGenetics Physicians & SurgeonsUpdated on Jul 25, 2019 View more like this | Visit ANCHORAGE, AK | Contact Market Data Forecast |
Recent Developments
Sema4 Company is a patient-centered health intelligence company, which is a leader in diagnostic testing. The company initiated on the idea that more information, increased engagement, deeper analysis will improve the treatment, diagnosis, and prevention of disease.
On February 2018, Sema4 released supplemental newborn screening test ‘Sema4 Natalis’ that is designed to identify 193 childhood-onset disorders or diseases. Moreover, there is a rising prevalence of depression amongst women globally, which rises the opportunity of defected birth. Thus, the increasing prevalence of depression amongst women has increasing the genetic testing market for the newborn screening.
To know more read @ https://www.marketdataforecast.com/market-reports/genetic-testing-market
Market Overview
Market Data Forecast published a report named as Genetic Testing Market. The global Genetic Testing Market worth was USD 54.36 Million in 2019 and it has estimated to reach at a CAGR of 9.86%, to reach USD 84.58 Million by 2024.
Report segmented as:
By Type:
Carrier Testing
Diagnostic Testing
Prenatal Testing
Neonatal Testing
By Application
Cancer Testing
Pharmacogenomics Testing
Prenatal Testing
Predisposition Testing
The rising awareness between the populations about early diagnosis coupled with increasing expenditure on anticipatory measures has fuelled popularity in the market.
Geographical Segmentation:
Based on geography, the market divided under many countries such as North America, Europe, Asia-Pacific and the Rest of the World. US has led the global Genetic Testing Market.
Key market players
23andMe
Abbott Molecular
deCODEme
BGI
Cepheid
BioMerieux
Biocartis
BioHelix
Bayer Diagnostics
Celera Genomics
Genentech
Counsyl
View a sample and decide @ https://www.marketdataforecast.com/market-reports/genetic-testing-market/request-sample
The Scope of the report:
The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed and the prospects with huge growth potential identified and debated.
About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: [email protected]
Tel: +1-888-702-9626
Website: https://www.marketdataforecast.com/
Sema4 Company is a patient-centered health intelligence company, which is a leader in diagnostic testing. The company initiated on the idea that more information, increased engagement, deeper analysis will improve the treatment, diagnosis, and prevention of disease.
On February 2018, Sema4 released supplemental newborn screening test ‘Sema4 Natalis’ that is designed to identify 193 childhood-onset disorders or diseases. Moreover, there is a rising prevalence of depression amongst women globally, which rises the opportunity of defected birth. Thus, the increasing prevalence of depression amongst women has increasing the genetic testing market for the newborn screening.
To know more read @ https://www.marketdataforecast.com/market-reports/genetic-testing-market
Market Overview
Market Data Forecast published a report named as Genetic Testing Market. The global Genetic Testing Market worth was USD 54.36 Million in 2019 and it has estimated to reach at a CAGR of 9.86%, to reach USD 84.58 Million by 2024.
Report segmented as:
By Type:
Carrier Testing
Diagnostic Testing
Prenatal Testing
Neonatal Testing
By Application
Cancer Testing
Pharmacogenomics Testing
Prenatal Testing
Predisposition Testing
The rising awareness between the populations about early diagnosis coupled with increasing expenditure on anticipatory measures has fuelled popularity in the market.
Geographical Segmentation:
Based on geography, the market divided under many countries such as North America, Europe, Asia-Pacific and the Rest of the World. US has led the global Genetic Testing Market.
Key market players
23andMe
Abbott Molecular
deCODEme
BGI
Cepheid
BioMerieux
Biocartis
BioHelix
Bayer Diagnostics
Celera Genomics
Genentech
Counsyl
View a sample and decide @ https://www.marketdataforecast.com/market-reports/genetic-testing-market/request-sample
The Scope of the report:
The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed and the prospects with huge growth potential identified and debated.
About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: [email protected]
Tel: +1-888-702-9626
Website: https://www.marketdataforecast.com/
